EGFR-IN-52
EGFR-IN-52 (Compound 4) is a potent EGFR inhibitor with IC50 values of 0.358, 86.02 and 432.67 µM against EGFR, EGFR L858R-TK and EGFR T790M-TK, respectively. EGFR-IN-52 shows cytotoxic activity against cancer cell lines and induces apoptosis[1].
Product Specifications
CAS Number
[454436-75-0]
UNSPSC
12352005
Target
Apoptosis; EGFR
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-52.html
Solubility
10 mM in DMSO
Smiles
CC1=C(C(N(N1C)C2=CC=CC=C2)=O)NC(NC3=CC=C4OCOC4=C3)=S
Molecular Formula
C19H18N4O3S
Molecular Weight
382.44
References & Citations
[1]Abbas SY, et al. Synthesis and anticancer activity of thiourea derivatives bearing a benzodioxole moiety with EGFR inhibitory activity, apoptosis assay and molecular docking study. Eur J Med Chem. 2020 Jul 15;198:112363.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EGFR/ErbB1/HER1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1244292-01 0.02 mg (E-Coli)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1244292-02 0.02 mg (Yeast)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details 
MBS1244292-03 0.1 mg (E-Coli)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1244292-04 0.1 mg (Yeast)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details 
MBS1244292-05 0.02 mg (Baculovirus)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details MBS1244292-06 0.02 mg (Mammalian-Cell)
Recombinant Anoxybacillus flavithermus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Ask
View Details